Tag: year

DUBAI, United Arab Emirates, June 21, 2026 (GLOBE NEWSWIRE) --

Pepeto just cleared a full exchange stress test and pushed past $10.28 million raised with the weekly pace still picking up, and what is building around this project is unlike anything the meme coin market has watched since the Dogecoin days.

DUBAI, United Arab Emirates, June 20, 2026 (GLOBE NEWSWIRE) --

Pepeto moved into final preparation ahead of a major exchange listing, and the presale became the fastest closing raise of 2026 as rounds close inside days, because $10.29 million is raised, 170% APY staking runs live, three products are in production, and wallets are pouring in at a pace that tells the reader the sharpest capital has already locked the entry before the listing pulls the price out of reach forever.

DUBAI, United Arab Emirates, June 20, 2026 (GLOBE NEWSWIRE) --

Ethereum-based new crypto Pepeto confirms progress on the DeFi tools designed to reshape how the entire DeFi space works, and the signals building around this presale match the pattern that appeared before Dogecoin turned ordinary wallets, the kind that never imagined seven figures, into millionaires overnight. Experienced traders expect the same outcome from Pepeto.

TORONTO, June 19, 2026 (GLOBE NEWSWIRE) -- BlackRock Asset Management Canada Limited (“BlackRock Canada”), an indirect, wholly-owned subsidiary of BlackRock, Inc. (“BlackRock”) (NYSE:BLK), today announced updated investment risk ratings of the iShares ETFs listed below, effective as of June 19, 2026:

TORONTO, 19 juin 2026 (GLOBE NEWSWIRE) -- Gestion d’actifs BlackRock Canada Limitée (« BlackRock Canada »), filiale indirecte en propriété exclusive de BlackRock, Inc. (« BlackRock ») (NYSE : BLK), a annoncé aujourd’hui avoir mis à jour les niveaux de risque de placement des FNB iShares énumérés ci-après, avec prise d’effet en date du 19 juin 2026 :

SAN CARLOS, Calif., June 19, 2026 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (“TIL”) therapies for patients with cancer, today announced that on June 18, 2026 (the “Date of Grant”), the Company approved the grant of inducement stock options covering an aggregate of 140,860 shares of Iovance’s common stock to twenty-seven new, non-executive employees.

New robotic window cleaner combines intelligent navigation, advanced safety features, and user-friendly operation to make window cleaning easier and more accessible